文献速递心脑血管急症重症综合管理与镇静镇痛

miR-376b-5p联合免疫炎症指标预测急性心肌梗死院内死亡

[miR-376b-5p and immune-inflammatory indicators for predicting in-hospital mortality in acute myocardial infarction].
PubMed 文献 · Zhonghua Wei Zhong Bing Ji Jiu Yi Xue · 2026-01-01
一句话结论AMI患者PCI术前血清miR-376b-5p联合NLR+SII+PLR可预测院内全因死亡,联合AUC达0.903。

前瞻性观察研究纳入316例接受PCI的AMI患者,PCI前采血检测miR-376b-5p、NLR、SII、PLR、hs-CRP。院内死亡52例,死亡组各指标均高于存活组。多因素回归显示NLR、SII、PLR、miR-376b-5p升高均为院内死亡独立危险因素。NLR+SII+PLR联合AUC为0.859,miR-376b-5p联合三项炎症指标AUC升至0.903,高于各单项指标。

要点

  • PCI术前miR-376b-5p升高是AMI院内死亡独立危险因素(OR=1.831,95%CI 1.282-2.616)。
  • NLR(OR=2.097,95%CI 1.453-3.027)与SII(OR=2.011,95%CI 1.286-3.144)升高均为独立危险因素。
  • PLR升高亦为独立危险因素(OR=1.067,95%CI 1.034-1.101)。
  • NLR+SII+PLR联合预测院内死亡AUC=0.859,敏感度82.69%、特异度76.89%。
  • miR-376b-5p联合NLR+SII+PLR的AUC升至0.903,敏感度88.46%、特异度82.58%。

适用人群与场景

  • 2023年6月至2025年6月衡水市人民医院心血管内科收治的316例急性心肌梗死患者,均接受急诊或择期PCI。
  • 采血时间点为PCI前(入院24小时内)采集外周静脉血。
  • 原文未提及排除人群及院前、ICU场景的适用性。

诊断标准与关键阈值

  • 结局事件为院内全因死亡,据此分为死亡组52例与存活组264例。
  • Killip III级在死亡组比例高于存活组(P<0.05)。
  • 原文未提及miR-376b-5p、NLR、SII、PLR的具体截断值或启动治疗阈值。

处置流程与药物剂量

  • 原文未提及基于上述指标的处置流程或药物剂量方案。

红旗征与不能漏的情况

  • 原文未提及需要立刻处理或不能漏诊的具体红旗征及对应处理。

研究设计与关键结果

  • 前瞻性观察研究,单中心(衡水市人民医院心血管内科),样本量316例,均接受急诊或择期PCI。
  • 主要终点为院内全因死亡:死亡组52例,存活组264例。
  • 死亡组Killip III级比例及血清miR-376b-5p、NLR、SII、PLR、hs-CRP水平均高于存活组(均P<0.05)。
  • 多因素logistic回归:NLR(OR=2.097,95%CI 1.453-3.027)、SII(OR=2.011,95%CI 1.286-3.144)、PLR(OR=1.067,95%CI 1.034-1.101)、miR-376b-5p(OR=1.831,95%CI 1.282-2.616)均为院内死亡独立危险因素(均P<0.05)。
  • ROC曲线:NLR+SII+PLR联合预测AUC=0.859,敏感度82.69%、特异度76.89%,高于各单项指标。
  • miR-376b-5p单项预测AUC=0.812,敏感度75.00%、特异度75.38%。
  • miR-376b-5p联合NLR+SII+PLR的AUC=0.903,敏感度88.46%、特异度82.58%,高于各单项指标(均P<0.05)。

证据类型、等级与局限

  • 证据类型:前瞻性观察性研究(单中心)。
  • 局限:单中心、观察性设计,原文未报告样本量估算、盲法及外部验证。

对床旁实践的改变

  • 对接受PCI的AMI患者,PCI前可检测miR-376b-5p、NLR、SII、PLR以辅助识别院内死亡高风险人群。
  • 联合指标(miR-376b-5p+NLR+SII+PLR)预测价值高于单项指标,但原文未给出临床决策阈值,不能直接作为治疗启动依据。
  • 原文未提及该预测模型对治疗决策或预后改善的影响,不改变现有再灌注及药物治疗方案。

指南或共识出处

  • 原文未提及

以上提炼依据论文摘要(全文未开放获取,或许可不允许翻译转载);全文请点「阅读原文」。

英文原文(摘要)· 点击展开

OBJECTIVE: To investigate the early predictive efficacy of serum microRNA-376b-5p (miR-376b-5p) combined with immuno-inflammatory markers for all-cause mortality during hospitalization in patients with acute myocardial infarction (AMI).

METHODS: A prospective observational study was conducted. A total of 316 patients with AMI admitted to the Department of Cardiovascular Medicine of Hengshui People's Hospital from June 2023 to June 2025 were enrolled. Peripheral venous blood was collected immediately before percutaneous coronary intervention (PCI, within 24 hours after admission) to detect serum miR-376b-5p, neutrophil/lymphocyte ratio (NLR), Systemic Immune Inflammation Index (SII), platelet/lymphocyte ratio (PLR) and high-sensitivity C-reactive protein (hs-CRP) levels. All patients underwent emergency or elective PCI. The outcome event was all-cause mortality during hospitalization, and patients were divided into a death group (52 cases) and a survival group (264 cases). The clinical data and the levels of the aforementioned indicators were compared between the two groups. Multivariate logistic regression analysis was used to identify the influencing factors of in-hospital mortality; receiver operator characteristic curves (ROC curves) were plotted to evaluate the predictive value of serum miR-376b-5p and immune inflammation indicators for in-hospital mortality risk in AMI patients, and the area under the curve (AUC) was calculated.

RESULTS: The proportion of patients with Killip class III in the death group and the levels of serum miR-376b-5p, NLR, SII, PLR, and hs-CRP were all higher than those in the survival group (all P<0.05). Multivariate logistic regression analysis showed that elevated levels of NLR [odds ratio (OR)=2.097, 95% confidence interval (95%CI) was 1.453-3.027], SII (OR=2.011, 95%CI was 1.286-3.144), PLR (OR=1.067, 95%CI was 1.034-1.101), and miR-376b-5p (OR=1.831, 95%CI was 1.282-2.616) were independent risk factors for in-hospital mortality in patients with AMI (all P<0.05). The ROC curve indicated that NLR, SII, and PLR all had predictive value for in-hospital mortality in patients with AMI, and the combined prediction of NLR+SII+PLR had a higher predictive value than each individual marker (AUC=0.859), with sensitivity and specificity of 82.69% and 76.89%, respectively. The AUC of serum miR-376b-5p for predicting in-hospital mortality in patients with AMI was 0.812, with sensitivity and specificity of 75.00% and 75.38%, respectively. The AUC of serum miR-376b-5p combined with NLR+SII+PLR increased to 0.903, which was higher than that of each individual marker (both P<0.05), with sensitivity and specificity of 88.46% and 82.58%, respectively.

CONCLUSIONS: Elevated serum miR-376b-5p, NLR, SII and PLR levels immediately before PCI are independent risk factors for in-hospital death in AMI patients. Serum miR-376b-5p combined with NLR+SII+PLR has a higher predictive value for in-hospital death in AMI patients.

来源:Zhonghua Wei Zhong Bing Ji Jiu Yi Xue,查看原文。版权归原作者所有。

参考来源

  1. Niu Y, Fu J, Zhang H, et al. [miR-376b-5p and immune-inflammatory indicators for predicting in-hospital mortality in acute myocardial infarction]. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2026. PMID: 42875241. doi:10.3760/cma.j.cn121430-20260324-00136

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。